Detailansicht

Wissensnetz

Person

Henning Sebastian Schäfer (1977-)

Name	Henning Sebastian Schäfer
Zeit	1977- (Lebensdaten)
Ort	Sonstiges Ausland / Unbekanntes Land
Weitere Angaben	Diss. Medizinische Fakultät an der Universität Freiburg im Breisgau
Datensatztyp	Person
GND-Nummer	13137656X
Datensatz-ID	13137656X
Beteiligt an alle anzeigen Evaluating the impact of a rigid and a deformable registration method of pre-treatment images for hypoxia-based dose painting Plasma extracellular vesicles in meningioma patients following radiotherapy as liquid biopsy- a prospective explorative biomarker study (ARO 2023-05/AG-NRO-07) The value of subcutaneous xenografts for individualised radiotherapy in HNSCC: robust gene signature correlates with radiotherapy outcome in patients and xenografts App-controlled treatment monitoring and support for patients with head and neck cancer undergoing radiotherapy: results from a prospective randomized controlled trial Interrater agreement of multi-professional case review as reference standard for specialist palliative care need: a mixed-methods study Multidisciplinary tumor board analysis: validation study of a central tool in tumor centers The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation A novel 2-metagene signature to identify high-risk HNSCC patients amongst those who are clinically at intermediate risk and are treated with PORT A novel 2-metagene signature to identify high-risk HNSCC patients amongst those who are clinically at intermediate risk and are treated with PORT Biopsy-derived oral keratinocytes – a model to potentially test for oral mucosa radiation sensitivity Development of a screening tool for the need of specialist palliative care in oncologic inpatients: study protocol for the ScreeningPALL Study Integration of p16/HPV DNA status with a 24-miRNA-defined molecular phenotype improves clinically relevant stratification of head and neck cancer patients Tumor DNA‐methylome derived epigenetic fingerprint identifies HPV‐negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT Transitioning the molecular tumor board from proof of concept to clinical routine: a german single-center analysis RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: a randomized multicenter phase II trial Personalized clinical decision making through implementation of a molecular tumor board: a German single-center experience Die Untersuchung des Transkriptionsfaktors RUNX2, insbesondere die RUNX2-Cbfβ-Interaktion [RUNX2-Cbf-Beta-Interaktion] in der Pathogenese der cleidocranialen Dysplasie

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Henning Sebastian Schäfer (1977-)

Evaluating the impact of a rigid and a deformable registration method of pre-treatment images for hypoxia-based dose painting

Plasma extracellular vesicles in meningioma patients following radiotherapy as liquid biopsy- a prospective explorative biomarker study (ARO 2023-05/AG-NRO-07)

The value of subcutaneous xenografts for individualised radiotherapy in HNSCC: robust gene signature correlates with radiotherapy outcome in patients and xenografts

App-controlled treatment monitoring and support for patients with head and neck cancer undergoing radiotherapy: results from a prospective randomized controlled trial

Interrater agreement of multi-professional case review as reference standard for specialist palliative care need: a mixed-methods study

Multidisciplinary tumor board analysis: validation study of a central tool in tumor centers

The influence of antibiotic administration on the outcomes of head-and-neck squamous cell carcinoma patients undergoing definitive (chemo)radiation

A novel 2-metagene signature to identify high-risk HNSCC patients amongst those who are clinically at intermediate risk and are treated with PORT

A novel 2-metagene signature to identify high-risk HNSCC patients amongst those who are clinically at intermediate risk and are treated with PORT

Biopsy-derived oral keratinocytes – a model to potentially test for oral mucosa radiation sensitivity

Development of a screening tool for the need of specialist palliative care in oncologic inpatients: study protocol for the ScreeningPALL Study

Integration of p16/HPV DNA status with a 24-miRNA-defined molecular phenotype improves clinically relevant stratification of head and neck cancer patients

Tumor DNA‐methylome derived epigenetic fingerprint identifies HPV‐negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy

A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT

A prospective single-center study on CNI-free GVHD prophylaxis with everolimus plus mycophenolate mofetil in allogeneic HCT

Transitioning the molecular tumor board from proof of concept to clinical routine: a german single-center analysis

RADIANCE – Radiochemotherapy with or without Durvalumab in the treatment of anal squamous cell carcinoma: a randomized multicenter phase II trial

Personalized clinical decision making through implementation of a molecular tumor board: a German single-center experience

Die Untersuchung des Transkriptionsfaktors RUNX2, insbesondere die RUNX2-Cbfβ-Interaktion [RUNX2-Cbf-Beta-Interaktion] in der Pathogenese der cleidocranialen Dysplasie